Par Drugs & Chemicals Ltd Competitors & Peer Comparison
Pharmaceuticals · Indian listed companies
Compare Par Drugs & Chemicals Ltd with 125 companies shown from the same industry classification, including Bal Pharma Ltd, Auro Laboratories Ltd, Achyut Healthcare Ltd. These are industry peers; their products, customers and business models may differ.
Selected-company price and ratio data: . Peer reporting dates can differ. Stored figures, not live quotes.
Compare valuation, size and returns
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Par Drugs & Chemicals Ltd | 151 Cr. | 123 | 180/78.0 | 10.4 | 91.0 | 0.00 % | 14.6 % | 9.95 % | 10.0 |
| Bal Pharma Ltd | 157 Cr. | 98.6 | 125/59.7 | 21.8 | 51.6 | 1.22 % | 9.75 % | 7.79 % | 10.0 |
| Auro Laboratories Ltd | 142 Cr. | 228 | 317/159 | 29.6 | 74.4 | 0.00 % | 9.52 % | 8.49 % | 10.0 |
| Achyut Healthcare Ltd | 137 Cr. | 5.66 | 10.0/4.70 | 427 | 1.45 | 0.00 % | 1.18 % | 0.96 % | 1.00 |
| Lactose (India) Ltd | 135 Cr. | 107 | 136/76.0 | 19.4 | 51.5 | 0.00 % | 11.3 % | 9.81 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 133 Cr. | 9.09 | 14.3/1.96 | 44.4 | 0.81 | 0.00 % | 22.9 % | 16.6 % | 1.00 |
| Brooks Laboratories Ltd | 173 Cr. | 58.8 | 132/36.3 | 13.1 | 41.6 | 0.00 % | 21.2 % | 22.0 % | 10.0 |
| Godavari Drugs Ltd | 127 Cr. | 117 | 135/69.7 | 32.7 | 74.8 | 0.00 % | 6.55 % | 6.14 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 125 Cr. | 57.8 | 76.8/38.3 | 75.5 | 0.00 % | 15.4 % | % | 10.0 | |
| Alpa Laboratories Ltd | 121 Cr. | 57.7 | 99.8/46.0 | 27.8 | 93.4 | 0.00 % | 8.91 % | 7.90 % | 10.0 |
| Vaishali Pharma Ltd | 107 Cr. | 8.17 | 11.6/4.75 | 25.1 | 5.29 | 0.00 % | 8.93 % | 6.02 % | 2.00 |
| Pharmaids Pharmaceuticals Ltd | 107 Cr. | 30.2 | 60.0/25.6 | 13.5 | 0.00 % | 18.5 % | 26.5 % | 10.0 | |
| Coral Laboratories Ltd | 201 Cr. | 562 | 679/360 | 10.6 | 585 | 0.36 % | 11.0 % | 7.79 % | 10.0 |
| Concord Drugs Ltd | 101 Cr. | 76.9 | 92.5/61.0 | 49.7 | 36.8 | 0.00 % | 5.19 % | 2.52 % | 10.0 |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Denis Chem Lab Ltd | 93.3 Cr. | 67.3 | 97.4/56.1 | 11.7 | 66.0 | 3.72 % | 14.0 % | 9.52 % | 10.0 |
| Nectar Lifescience Ltd | 211 Cr. | 11.0 | 22.5/9.20 | 30.0 | 0.00 % | 0.05 % | 31.3 % | 1.00 | |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | / | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Fervent Synergies Ltd | 77.0 Cr. | 15.4 | 26.0/13.0 | 21.2 | 11.4 | 0.00 % | 7.21 % | 7.22 % | 10.0 |
| Everest Organics Ltd | 235 Cr. | 236 | 536/197 | 44.8 | 77.7 | 0.00 % | 12.0 % | 7.63 % | 10.0 |
| Cian Healthcare Ltd | 62.4 Cr. | 25.0 | 25.0/4.72 | 3.42 | 0.00 % | 15.1 % | 49.2 % | 10.0 | |
| Gennex Laboratories Ltd | 241 Cr. | 9.90 | 17.2/7.05 | 12.8 | 9.16 | 0.00 % | 11.8 % | 10.5 % | 1.00 |
| Vivimed Labs Ltd | 53.0 Cr. | 6.28 | 29.4/4.75 | 25.4 | 0.00 % | 65.2 % | % | 2.00 | |
| ANG Lifesciences India Ltd | 50.4 Cr. | 38.6 | 49.7/17.6 | 47.6 | 0.00 % | 1.14 % | 7.38 % | 10.0 | |
| Mangalam Drugs and Organics Ltd | 49.8 Cr. | 31.5 | 74.0/22.7 | 65.3 | 0.00 % | 14.0 % | 34.8 % | 10.0 | |
| Biofil Chemicals & Pharmaceuticals Ltd | 49.5 Cr. | 30.4 | 46.8/25.6 | 103 | 13.2 | 0.00 % | 2.97 % | 2.83 % | 10.0 |
| Lyka Labs Ltd | 262 Cr. | 72.5 | 105/44.1 | 25.9 | 0.00 % | 5.98 % | 10.2 % | 10.0 | |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 0.53/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Bacil Pharma Ltd | 38.4 Cr. | 26.8 | 61.8/10.6 | 59.1 | 17.3 | 0.00 % | 3.93 % | 6.21 % | 10.0 |
| Bharat Immunological & Biological Corporation Ltd | 35.8 Cr. | 8.28 | 22.6/7.11 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Chandra Bhagat Pharma Ltd | 35.4 Cr. | 46.9 | 53.0/29.7 | 11.6 | 43.9 | 0.00 % | 12.1 % | 9.67 % | 10.0 |
| Gujarat Terce Laboratories Ltd | 27.1 Cr. | 34.8 | 59.8/29.0 | 12.2 | 12.5 | 0.00 % | 39.2 % | 30.2 % | 10.0 |
| BDH Industries Ltd | 283 Cr. | 491 | 610/340 | 24.2 | 134 | 1.02 % | 20.5 % | 14.8 % | 10.0 |
| Colinz Laboratories Ltd | 18.4 Cr. | 73.0 | 87.9/36.1 | 36.8 | 39.9 | 0.00 % | 7.20 % | 5.23 % | 10.0 |
| Checkpoint Trends Ltd | 18.0 Cr. | 32.8 | 144/28.4 | 14.6 | 42.5 | 0.00 % | 15.0 % | 12.7 % | 10.0 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Desh Rakshak Aushdhalaya Ltd | 15.3 Cr. | 26.9 | 59.6/22.4 | 27.9 | 23.3 | 0.00 % | 7.50 % | 5.59 % | 10.0 |
| Beryl Drugs Ltd | 13.1 Cr. | 25.9 | 27.6/15.9 | 21.2 | 19.5 | 0.00 % | 7.25 % | 4.34 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 11.4 Cr. | 75.9 | 153/70.0 | 8.60 | 0.00 % | 0.28 % | 0.28 % | 10.0 | |
| Dipna Pharmachem Ltd | 11.2 Cr. | 4.28 | 25.0/3.90 | 4.28 | 23.7 | 0.00 % | 7.64 % | 5.22 % | 10.0 |
| Adline Chem Lab Ltd | 9.24 Cr. | 15.8 | 16.2/7.60 | 3.03 | 0.00 % | 1,267 % | % | 10.0 | |
| Ganga Pharmaceuticals Ltd | 7.39 Cr. | 12.5 | 14.0/9.35 | 73.9 | 14.1 | 0.00 % | 2.90 % | 1.30 % | 10.0 |
| Brawn Biotech Ltd | 7.35 Cr. | 24.5 | 24.7/17.7 | 8.65 | 14.5 | 0.00 % | 0.00 % | 24.4 % | 10.0 |
| Decipher Labs Ltd | 5.73 Cr. | 5.67 | 11.0/5.00 | 20.5 | 0.00 % | 16.7 % | 14.2 % | 10.0 | |
| Amerise Biosciences Ltd | 5.42 Cr. | 0.82 | 1.03/0.50 | 0.82 | 0.00 % | 0.37 % | 0.37 % | 1.00 | |
| Fabino Enterprises Ltd | 4.27 Cr. | 20.3 | 27.0/13.0 | 18.7 | 0.00 % | 6.22 % | 8.76 % | 10.0 | |
| MPS Pharmaa Ltd | 3.98 Cr. | 2.08 | 2.08/1.57 | 0.04 | 0.00 % | 13.1 % | 177 % | 10.0 | |
| Evoq Remedies Ltd | 3.78 Cr. | 1.52 | 6.11/1.35 | 17.8 | 0.00 % | 0.56 % | 0.54 % | 10.0 | |
| Aarey Drugs & Pharmaceuticals Ltd | 346 Cr. | 108 | 109/50.3 | 83.1 | 53.0 | 0.00 % | 5.58 % | 2.75 % | 10.0 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Albert David Ltd | 464 Cr. | 813 | 932/580 | 20.6 | 686 | 0.62 % | 0.82 % | 0.44 % | 10.0 |
| Wanbury Ltd | 696 Cr. | 198 | 360/162 | 16.2 | 18.1 | 0.00 % | 36.6 % | 76.5 % | 10.0 |
| Kilitch Drugs (India) Ltd | 845 Cr. | 242 | 268/117 | 28.1 | 80.0 | 0.00 % | 13.4 % | 10.6 % | 10.0 |
| Anuh Pharma Ltd | 878 Cr. | 87.6 | 99.5/66.7 | 19.9 | 35.1 | 1.71 % | 14.9 % | 10.7 % | 5.00 |
| Bafna Pharmaceuticals Ltd | 951 Cr. | 402 | 409/94.8 | 122 | 40.6 | 0.00 % | 11.9 % | 12.3 % | 10.0 |
| Themis Medicare Ltd | 1,052 Cr. | 113 | 147/65.0 | 43.3 | 0.44 % | 2.74 % | 0.41 % | 1.00 | |
| Lincoln Pharmaceuticals Ltd | 1,121 Cr. | 560 | 770/440 | 11.6 | 378 | 0.32 % | 16.3 % | 12.3 % | 10.0 |
| Kopran Ltd | 1,237 Cr. | 256 | 296/107 | 49.5 | 110 | 1.17 % | 6.65 % | 4.91 % | 10.0 |
| TTK Healthcare Ltd | 1,458 Cr. | 1,034 | 1,250/735 | 19.0 | 789 | 0.97 % | 8.04 % | 6.30 % | 10.0 |
| Amrutanjan Health Care Ltd | 1,508 Cr. | 522 | 760/476 | 24.2 | 128 | 0.94 % | 24.8 % | 18.4 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,553 Cr. | 235 | 265/155 | 33.0 | 41.2 | 1.70 % | 22.7 % | 17.3 % | 2.00 |
| Fermenta Biotech Ltd | 1,646 Cr. | 557 | 580/249 | 30.1 | 138 | 0.67 % | 20.6 % | 16.4 % | 5.00 |
| Hester Biosciences Ltd | 1,844 Cr. | 2,167 | 2,684/1,239 | 34.7 | 423 | 0.51 % | 15.2 % | 15.9 % | 10.0 |
| Syncom Formulations (India) Ltd | 2,185 Cr. | 23.2 | 27.5/10.2 | 25.7 | 4.39 | 0.43 % | 24.8 % | 17.6 % | 1.00 |
| Beta Drugs Ltd | 2,208 Cr. | 1,991 | 2,808/990 | 48.4 | 241 | 0.00 % | 19.2 % | 18.8 % | 10.0 |
| Panacea Biotec Ltd | 2,230 Cr. | 363 | 648/292 | 136 | 0.00 % | 2.43 % | 2.42 % | 1.00 | |
| Fredun Pharmaceuticals Ltd | 2,258 Cr. | 1,363 | 1,600/454 | 50.8 | 170 | 0.02 % | 21.5 % | 15.8 % | 10.0 |
| Indoco Remedies Ltd | 2,276 Cr. | 247 | 317/162 | 102 | 0.08 % | 0.96 % | 9.36 % | 2.00 | |
| Venus Remedies Ltd | 2,370 Cr. | 1,747 | 2,044/432 | 20.4 | 497 | 0.57 % | 20.7 % | 15.6 % | 10.0 |
| Dishman Carbogen Amcis Ltd | 2,390 Cr. | 152 | 306/128 | 132 | 426 | 0.00 % | 3.14 % | 1.58 % | 2.00 |
| Hikal Ltd | 2,777 Cr. | 225 | 261/146 | 65.5 | 97.2 | 0.27 % | 3.50 % | 2.21 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,024 Cr. | 270 | 420/252 | 19.2 | 146 | 1.98 % | 14.0 % | 10.2 % | 2.00 |
| Solara Active Pharma Sciences Ltd | 3,315 Cr. | 683 | 774/422 | 776 | 346 | 0.00 % | 4.86 % | 0.13 % | 10.0 |
| Ind-Swift Laboratories Ltd | 3,401 Cr. | 391 | 425/87.0 | 52.3 | 159 | 0.00 % | 4.86 % | 4.02 % | 10.0 |
| Kwality Pharmaceuticals Ltd | 3,663 Cr. | 3,530 | 3,949/829 | 44.8 | 321 | 0.00 % | 23.9 % | 22.5 % | 10.0 |
| Aarti Drugs Limited | 3,811 Cr. | 418 | 534/319 | 22.0 | 154 | 0.48 % | 11.7 % | 12.7 % | 10.0 |
| Unichem Laboratories Ltd | 3,857 Cr. | 548 | 687/278 | 31.6 | 386 | 0.00 % | 4.13 % | 3.17 % | 2.00 |
| Gufic BioSciences Ltd | 4,237 Cr. | 423 | 468/268 | 57.6 | 66.2 | 0.02 % | 12.2 % | 9.98 % | 1.00 |
| SMS Pharmaceuticals Ltd | 4,428 Cr. | 472 | 494/262 | 48.9 | 85.9 | 0.08 % | 12.9 % | 11.9 % | 1.00 |
| Zota Health Care Ltd | 4,428 Cr. | 1,279 | 1,740/1,022 | 200 | 0.08 % | 8.47 % | 15.0 % | 10.0 | |
| Gujarat Themis Biosyn Ltd | 4,855 Cr. | 374 | 479/225 | 99.7 | 26.4 | 0.18 % | 18.1 % | 17.4 % | 1.00 |
| RPG Life Sciences Ltd | 4,858 Cr. | 2,933 | 3,130/1,731 | 41.6 | 366 | 0.82 % | 25.7 % | 19.3 % | 8.00 |
| FDC Ltd | 5,349 Cr. | 329 | 474/313 | 17.4 | 153 | 1.52 % | 15.4 % | 11.2 % | 1.00 |
| Orchid Pharma Ltd | 6,022 Cr. | 1,007 | 1,144/471 | 333 | 300 | 0.00 % | 1.86 % | 1.49 % | 10.0 |
| IOL Chemicals & Pharmaceuticals Ltd | 6,464 Cr. | 220 | 224/67.1 | 36.6 | 61.3 | 0.45 % | 11.3 % | 8.42 % | 2.00 |
| Sanofi India Ltd | 7,015 Cr. | 3,047 | 4,898/3,000 | 20.5 | 359 | 2.46 % | 57.5 % | 43.0 % | 10.0 |
| Bliss GVS Pharma Ltd | 7,247 Cr. | 682 | 745/118 | 52.7 | 113 | 0.22 % | 16.9 % | 11.8 % | 1.00 |
| Entero Healthcare Solutions Ltd | 7,378 Cr. | 1,697 | 1,920/944 | 57.2 | 388 | 0.00 % | 10.5 % | 6.94 % | 10.0 |
| Morepen Laboratories Ltd | 7,888 Cr. | 144 | 145/33.0 | 67.2 | 22.8 | 0.14 % | 8.05 % | 5.33 % | 2.00 |
| Suven Life Sciences Ltd | 8,741 Cr. | 309 | 403/124 | 22.4 | 0.00 % | 79.5 % | 81.5 % | 1.00 | |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Procter & Gamble Health Ltd | 8,805 Cr. | 5,306 | 6,975/4,700 | 26.4 | 316 | 2.92 % | 83.9 % | 61.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 8,838 Cr. | 975 | 1,002/584 | 41.0 | 234 | 0.36 % | 10.7 % | 8.59 % | 5.00 |
| Blue Jet Healthcare Ltd | 10,198 Cr. | 538 | 693/325 | 43.4 | 78.4 | 0.22 % | 26.1 % | 19.4 % | 2.00 |
| Marksans Pharma Ltd | 13,976 Cr. | 308 | 351/155 | 27.0 | 66.7 | 0.28 % | 18.8 % | 15.2 % | 1.00 |
| Concord Biotech Ltd | 14,175 Cr. | 1,356 | 1,648/987 | 49.8 | 193 | 0.56 % | 17.4 % | 12.6 % | 1.00 |
| Astrazeneca Pharma India Ltd | 14,795 Cr. | 5,918 | 9,850/5,802 | 85.3 | 349 | 0.61 % | 29.3 % | 23.3 % | 2.00 |
| Jubilant Pharmova Ltd | 15,525 Cr. | 975 | 1,185/784 | 40.0 | 445 | 0.51 % | 8.99 % | 6.53 % | 1.00 |
| ERIS Lifesciences Ltd | 15,897 Cr. | 1,146 | 1,740/1,141 | 24.2 | 282 | 0.63 % | 14.1 % | 18.7 % | 1.00 |
| Natco Pharma Ltd | 16,145 Cr. | 824 | 1,217/786 | 14.1 | 470 | 0.61 % | 17.4 % | 17.1 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 16,389 Cr. | 834 | 998/635 | 22.0 | 289 | 1.44 % | 12.6 % | 13.4 % | 2.00 |
| Cohance Lifesciences Ltd | 17,487 Cr. | 457 | 918/267 | 162 | 102 | 0.00 % | 5.81 % | 4.89 % | 1.00 |
| Pfizer Ltd | 17,633 Cr. | 3,852 | 5,578/3,792 | 22.9 | 919 | 1.95 % | 24.1 % | 18.0 % | 10.0 |
| Caplin Point Laboratories Ltd | 20,136 Cr. | 2,649 | 2,991/1,500 | 30.3 | 443 | 0.30 % | 24.2 % | 20.9 % | 2.00 |
| Shilpa Medicare Ltd | 21,008 Cr. | 1,074 | 1,096/260 | 73.9 | 132 | 0.06 % | 10.9 % | 8.99 % | 1.00 |
| Granules India Ltd | 23,058 Cr. | 845 | 924/520 | 35.5 | 205 | 0.21 % | 15.5 % | 13.8 % | 1.00 |
| Acutaas Chemicals Ltd | 25,873 Cr. | 3,157 | 3,740/1,375 | 67.0 | 202 | 0.08 % | 31.6 % | 24.0 % | 5.00 |
| Neuland Laboratories Ltd | 28,127 Cr. | 21,905 | 24,235/11,500 | 56.5 | 1,461 | 0.16 % | 26.5 % | 21.2 % | 10.0 |
| Wockhardt Ltd | 35,397 Cr. | 2,176 | 2,422/1,087 | 88.8 | 304 | 0.00 % | 7.55 % | 6.11 % | 5.00 |
| J B Chemicals & Pharmaceuticals Ltd | 38,677 Cr. | 2,409 | 2,526/1,642 | 53.8 | 259 | 0.91 % | 25.4 % | 18.9 % | 1.00 |
| Ajanta Pharma Ltd | 44,608 Cr. | 3,570 | 3,797/2,380 | 39.3 | 362 | 0.90 % | 34.5 % | 27.1 % | 2.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 44,622 Cr. | 2,634 | 3,121/2,088 | 42.4 | 134 | 2.16 % | 61.4 % | 45.6 % | 10.0 |
| Ipca Laboratories Ltd | 49,181 Cr. | 1,938 | 2,039/1,252 | 35.8 | 318 | 0.31 % | 17.0 % | 15.7 % | 1.00 |
| Gland Pharma Ltd | 51,988 Cr. | 3,151 | 3,171/1,574 | 36.8 | 656 | 0.63 % | 17.4 % | 12.8 % | 1.00 |
| Abbott India Ltd | 55,346 Cr. | 26,115 | 30,655/25,135 | 34.3 | 2,247 | 2.01 % | 44.8 % | 34.4 % | 10.0 |
| Biocon Ltd | 58,669 Cr. | 360 | 447/338 | 80.7 | 210 | 0.14 % | 3.61 % | 1.40 % | 5.00 |
| Alkem Laboratories Ltd | 63,973 Cr. | 5,350 | 5,934/5,051 | 28.2 | 1,156 | 0.99 % | 21.2 % | 18.9 % | 2.00 |
| Glenmark Pharmaceuticals Ltd | 64,412 Cr. | 2,282 | 2,538/1,793 | 20.6 | 372 | 0.22 % | 39.8 % | 23.6 % | 1.00 |
| Glenmark Life Sciences Ltd | 64,624 Cr. | 2,295 | 2,538/1,793 | 20.7 | 372 | 0.22 % | 39.8 % | 23.6 % | 1.00 |
| Lupin Ltd | 88,806 Cr. | 1,942 | 2,530/1,900 | 14.9 | 491 | 0.89 % | 29.9 % | 28.7 % | 2.00 |
| Aurobindo Pharma Ltd | 97,686 Cr. | 1,693 | 1,740/1,066 | 25.8 | 652 | 0.24 % | 12.9 % | 10.1 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,00,479 Cr. | 1,204 | 1,415/1,080 | 31.2 | 454 | 0.66 % | 13.0 % | 11.2 % | 1.00 |
| Mankind Pharma Ltd | 1,03,222 Cr. | 2,500 | 2,642/1,910 | 45.6 | 397 | 0.04 % | 13.7 % | 13.8 % | 1.00 |
| Cipla Ltd | 1,07,221 Cr. | 1,327 | 1,673/1,166 | 30.0 | 426 | 0.98 % | 15.5 % | 11.6 % | 2.00 |
| Laurus Labs Ltd | 1,08,062 Cr. | 2,000 | 2,065/843 | 124 | 97.3 | 0.10 % | 16.0 % | 15.2 % | 2.00 |
| Torrent Pharmaceuticals Ltd | 1,82,155 Cr. | 4,772 | 5,250/3,480 | 81.6 | 248 | 0.80 % | 15.2 % | 27.4 % | 5.00 |
| Industry Average | 17,536.19 Cr | 1,246.28 | 54.77 | 211.24 | 0.39% | 26.16% | 16.59% | 6.06 |
How to use this peer comparison
Start with similar company sizes, then compare P/E with ROCE and ROE. A lower P/E alone does not establish better value. Negative earnings, unusual items, debt and different reporting dates can make ratios unsuitable for direct comparison.
The company list is ordered by market-cap proximity to Par Drugs & Chemicals Ltd, with P/E as a secondary comparison. The industry-average row uses available stored values across the industry, which can include companies beyond the rows shown. Missing values are not zero.
Open each company report for financial statements and its cited sources. Industry classifications indicate a research peer group, not a verified list of direct commercial competitors.
Read the full Par Drugs & Chemicals Ltd analysis · Explore all Pharmaceuticals stocks